FI933391L - Triazolyltiometyltio-cefalosporin-hydroklorid, dess kristalliserad hydrat samt foerfarande foer deras framstaellning - Google Patents

Triazolyltiometyltio-cefalosporin-hydroklorid, dess kristalliserad hydrat samt foerfarande foer deras framstaellning Download PDF

Info

Publication number
FI933391L
FI933391L FI933391A FI933391A FI933391L FI 933391 L FI933391 L FI 933391L FI 933391 A FI933391 A FI 933391A FI 933391 A FI933391 A FI 933391A FI 933391 L FI933391 L FI 933391L
Authority
FI
Finland
Prior art keywords
triazolylthiomethylthio
kristalserada
hydrat
dess
foerfarande foer
Prior art date
Application number
FI933391A
Other languages
English (en)
Finnish (fi)
Other versions
FI933391A7 (fi
FI933391A0 (fi
Inventor
Hisanori Takahashi
Yutaka Ide
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of FI933391A0 publication Critical patent/FI933391A0/fi
Publication of FI933391L publication Critical patent/FI933391L/fi
Publication of FI933391A7 publication Critical patent/FI933391A7/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI933391A 1992-07-31 1993-07-29 Triatsolyylitiometyylitio-kefalosporiini-hydrokloridi, sen kiteytetty hydraatti sekä menetelmä niiden valmistamiseksi FI933391A7 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP20496592 1992-07-31

Publications (3)

Publication Number Publication Date
FI933391A0 FI933391A0 (fi) 1993-07-29
FI933391L true FI933391L (fi) 1994-02-01
FI933391A7 FI933391A7 (fi) 1994-02-01

Family

ID=16499234

Family Applications (1)

Application Number Title Priority Date Filing Date
FI933391A FI933391A7 (fi) 1992-07-31 1993-07-29 Triatsolyylitiometyylitio-kefalosporiini-hydrokloridi, sen kiteytetty hydraatti sekä menetelmä niiden valmistamiseksi

Country Status (23)

Country Link
US (1) US5407929A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0581552B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR100245938B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN (1) CN1037683C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE165360T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU657866B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BR (1) BR9303235A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2101502A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE69318077T2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2115725T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI933391A7 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR3026699T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU219637B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL106516A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MX (1) MX9304611A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO303734B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ248285A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PH (1) PH30109A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PL (2) PL172835B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
RU (1) RU2118959C1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TW (1) TW307769B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
UA (1) UA37181C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA935529B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1953162B9 (de) * 2001-02-24 2012-10-31 Boehringer Ingelheim Pharma GmbH & Co. KG Xanthinderivate, deren Herstellung und deren Verwendung als Arzneimittel
AT413282B (de) * 2002-02-01 2006-01-15 Sandoz Ag Kristalline salze der 7-(((5-amino-1,2,4-thiadiazol-3-yl) (fluoromethoxy-imino)acetyl)amino)-3- ((imino-1-piperazinylmethyl)
KR20030076759A (ko) * 2002-03-21 2003-09-29 주식회사 엘지생명과학 신규 세팔로스포린 화합물 및 그의 제조 방법
US7407955B2 (en) 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
US6727277B1 (en) 2002-11-12 2004-04-27 Kansas State University Research Foundation Compounds affecting cholesterol absorption
DE202004021379U1 (de) 2003-02-12 2008-02-21 Ciba Specialty Chemicals Holding Inc. Kristalline Formen von Pitivastatin Calcium
SI1606293T1 (sl) 2003-03-27 2009-10-31 Basilea Pharmaceutica Ag Cefalosporin v kristalni obliki
US7501426B2 (en) * 2004-02-18 2009-03-10 Boehringer Ingelheim International Gmbh 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
DE102004054054A1 (de) 2004-11-05 2006-05-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
DE102005035891A1 (de) * 2005-07-30 2007-02-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
EP2016079A1 (de) 2006-05-04 2009-01-21 Boehringer Ingelheim International GmbH Polymorphe
EP1852108A1 (en) 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG DPP IV inhibitor formulations
PE20080251A1 (es) * 2006-05-04 2008-04-25 Boehringer Ingelheim Int Usos de inhibidores de dpp iv
JP5769966B2 (ja) * 2007-08-17 2015-08-26 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Fab関連疾患治療用プリン誘導体
AR071175A1 (es) 2008-04-03 2010-06-02 Boehringer Ingelheim Int Composicion farmaceutica que comprende un inhibidor de la dipeptidil-peptidasa-4 (dpp4) y un farmaco acompanante
PE20100156A1 (es) * 2008-06-03 2010-02-23 Boehringer Ingelheim Int Tratamiento de nafld
KR20190016601A (ko) 2008-08-06 2019-02-18 베링거 인겔하임 인터내셔날 게엠베하 메트포르민 요법이 부적합한 환자에서의 당뇨병 치료
UY32030A (es) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
ES2764251T3 (es) * 2008-08-15 2020-06-02 Boehringer Ingelheim Int Inhibidores de DPP-4 para uso en el tratamiento de curación de heridas en pacientes diabéticos
JP2012502081A (ja) 2008-09-10 2012-01-26 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 糖尿病及び関連症状の治療のための組み合わせ治療
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
AU2009331471B2 (en) 2008-12-23 2015-09-03 Boehringer Ingelheim International Gmbh Salt forms of organic compound
AR074990A1 (es) 2009-01-07 2011-03-02 Boehringer Ingelheim Int Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina
JP2013512229A (ja) 2009-11-27 2013-04-11 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 遺伝子型が同定された糖尿病患者のリナグリプチン等のddp−iv阻害薬による治療
EP2566469B1 (en) 2010-05-05 2022-12-21 Boehringer Ingelheim International GmbH Combination therapy
EP3366304B1 (en) 2010-06-24 2020-05-13 Boehringer Ingelheim International GmbH Diabetes therapy
AR083878A1 (es) 2010-11-15 2013-03-27 Boehringer Ingelheim Int Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento
DK2731947T3 (en) 2011-07-15 2019-04-23 Boehringer Ingelheim Int SUBSTITUTED DIMERIC QUINAZOLINE DERIVATIVE, PREPARATION AND USE thereof IN PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF TYPE I AND TYPE II DIABETES
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
US20130303462A1 (en) 2012-05-14 2013-11-14 Boehringer Ingelheim International Gmbh Use of a dpp-4 inhibitor in podocytes related disorders and/or nephrotic syndrome
ES2929025T3 (es) 2012-05-14 2022-11-24 Boehringer Ingelheim Int Linagliptina, un derivado de xantina como inhibidor de dpp-4, para su uso en el tratamiento del SRIS y/o de la septicemia
WO2013174767A1 (en) 2012-05-24 2013-11-28 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
JP6615109B2 (ja) 2014-02-28 2019-12-04 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Dpp−4阻害薬の医学的使用
CN109310697A (zh) 2016-06-10 2019-02-05 勃林格殷格翰国际有限公司 利格列汀和二甲双胍的组合

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES475573A1 (es) * 1977-07-12 1980-01-16 Fujisawa Pharmaceutical Co Un procedimiento para preparar nuevos compuestos de cefem
IE65926B1 (en) * 1990-07-19 1995-11-29 Shionogi & Co Thioalkylthio cephalosporin derivatives

Also Published As

Publication number Publication date
KR940005636A (ko) 1994-03-22
AU4422793A (en) 1994-02-03
NO932745L (no) 1994-02-01
NO932745D0 (no) 1993-07-30
NO303734B1 (no) 1998-08-24
TW307769B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1997-06-11
US5407929A (en) 1995-04-18
PL172830B1 (pl) 1997-12-31
DE69318077D1 (de) 1998-05-28
DE69318077T2 (de) 1998-10-29
IL106516A0 (en) 1993-11-15
MX9304611A (es) 1994-02-28
FI933391A7 (fi) 1994-02-01
ATE165360T1 (de) 1998-05-15
HU219637B (hu) 2001-06-28
HUT68602A (en) 1995-06-28
NZ248285A (en) 1994-07-26
CA2101502A1 (en) 1994-02-01
PH30109A (en) 1996-12-27
CN1089948A (zh) 1994-07-27
EP0581552A3 (en) 1994-06-01
CN1037683C (zh) 1998-03-11
KR100245938B1 (ko) 2000-04-01
BR9303235A (pt) 1994-03-01
IL106516A (en) 1998-06-15
ZA935529B (en) 1994-02-24
PL172835B1 (pl) 1997-12-31
ES2115725T3 (es) 1998-07-01
HU9302194D0 (en) 1993-10-28
EP0581552B1 (en) 1998-04-22
FI933391A0 (fi) 1993-07-29
EP0581552A2 (en) 1994-02-02
GR3026699T3 (en) 1998-07-31
RU2118959C1 (ru) 1998-09-20
UA37181C2 (uk) 2001-05-15
AU657866B2 (en) 1995-03-23
PL299870A1 (en) 1994-02-07

Similar Documents

Publication Publication Date Title
FI933391L (fi) Triazolyltiometyltio-cefalosporin-hydroklorid, dess kristalliserad hydrat samt foerfarande foer deras framstaellning
FI934460A7 (fi) Karboxylsyraderivat, laekemedel innehaollande dessa foereningar samt foerfaranden foer deras framstaellning
DE69410447D1 (de) Ereigniskorrelation
FI922601L (fi) Haollfast dekorationslaminat med utomordentligt utseende och rengoerbarhet, samt foerfarande foer dess tillverkning
FI924644A7 (fi) Skruvhaollare foer en kontinuerlig skruvmejsel, samt ett foerfarande foer dess framstaellning
FI925126A0 (fi) Luftsepareringscykel, som omfattar flerstegsfoervaermare och dubbelkolonn, fungerande under kompression och hoegt tryck samt dess integration med gasturbiner
FI932999A7 (fi) Foerfarande foer lageravdragning, lageravdragare samt anvaendning daerav
FI924141A7 (fi) Optisk kommutator samt dess tilverkningsfoerfarande
FI930930A0 (fi) Cellulosaprodukt som innehaoller en olefinoxidpolymer samt foerfarande foer dess framstaellning
FI931414L (fi) Imidazolderivat, foerfarande foer deras framstaellning samt deras anvaendning i terapi
DK0723738T3 (da) Magasinarrangement
FI934875A0 (fi) Foerfarande foer att saenda radiosignaler samt en TDMA-saendarmottagare
FI933980A0 (fi) Skyddsplagg foer hygienkraevande objekt, saosom operationssalar
FI934313L (fi) Foerfarande foer framstaellning av fiberfoerstaerkt, termoplastiskt aemne samt anordning foer dess genomfoerande
FI933408L (fi) Ksylanas, ksylanas producerande bacillus-stammar samt deras utnyttjande
FI935478A0 (fi) Sollins och dess baerare och framstaellningsfoerfarande samt anordning foer producering och ackumulering av vaete, elektricitet, aonga och vaerme daermed samt pumpning av vaetska
FI921247L (fi) Vattenhaltig lackspray-skydds- belaeggning foer spraykammare samt foerfarande foer dess tillverkning.
FI924791L (fi) Xantatdisulfidgrupper innehaollande polymerer, foerfarande foer deras framstaellning samt deras anvaendning
FI923229L (fi) Isolerad takplatta samt foerfarande foer dess framstaellning
FI930983L (fi) Raelsfordonhjul, foerfarande foer dess saeghaerdning samt anordning foer genomfoerande av foerfarandet
DE59410412D1 (de) Bislactone
FI930287A0 (fi) Plastroer eller -profil med flera avdelningar, foerfarande foer dess framstaellning samt foerbindningsstycke
FI894589A0 (fi) Underlagsmaterial foer parkettgolv samt foerfarande foer dess framstaellning.
FI930961A0 (fi) Matstation foer koettboskap, saerskilt svin
FI954385A0 (fi) Loedpasta, dess anvaendning samt loedfoerfarande